This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Sep 11;325(5946):1319.

doi: 10.1126/science.1181224.

Redefining cancer research

PMID: 19745119
DOI: 10.1126/science.1181224

Editorial

Redefining cancer research

Bruce Alberts. Science. 2009.

. 2009 Sep 11;325(5946):1319.

doi: 10.1126/science.1181224.

Author

PMID: 19745119
DOI: 10.1126/science.1181224

No abstract available

PubMed Disclaimer

Similar articles

Facilitating patient-centered cancer research and a new era of drug discovery.
Niederhuber JE. Niederhuber JE. Oncologist. 2009 Apr;14(4):311-2. doi: 10.1634/theoncologist.2009-0051. Epub 2009 Apr 13. Oncologist. 2009. PMID: 19365096 No abstract available.
Factors influencing development of new therapeutics for oncology.
Winquist RJ, Boucher DM. Winquist RJ, et al. Curr Opin Pharmacol. 2010 Aug;10(4):353-5. doi: 10.1016/j.coph.2010.06.011. Epub 2010 Jul 14. Curr Opin Pharmacol. 2010. PMID: 20634136 No abstract available.
Cancer research. As questions grow, Duke halts trials, launches investigation.
Couzin-Frankel J. Couzin-Frankel J. Science. 2010 Aug 6;329(5992):614-5. doi: 10.1126/science.329.5992.614. Science. 2010. PMID: 20688986 No abstract available.
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
Pors K, Goldberg FW, Leamon CP, Rigby AC, Snyder SA, Falconer RA. Pors K, et al. Drug Discov Today. 2009 Nov;14(21-22):1045-50. doi: 10.1016/j.drudis.2009.07.004. Epub 2009 Jul 26. Drug Discov Today. 2009. PMID: 19638319 Review.
Targeting the DNA damage response in cancer.
Ljungman M. Ljungman M. Chem Rev. 2009 Jul;109(7):2929-50. doi: 10.1021/cr900047g. Chem Rev. 2009. PMID: 19545147 Review. No abstract available.

See all similar articles

Cited by

Detection and characterization of translational research in cancer and cardiovascular medicine.
Jones DS, Cambrosio A, Mogoutov A. Jones DS, et al. J Transl Med. 2011 May 11;9:57. doi: 10.1186/1479-5876-9-57. J Transl Med. 2011. PMID: 21569299 Free PMC article.
Novel strategies for drug discovery based on Intrinsically Disordered Proteins (IDPs).
Wang J, Cao Z, Zhao L, Li S. Wang J, et al. Int J Mol Sci. 2011;12(5):3205-19. doi: 10.3390/ijms12053205. Epub 2011 May 17. Int J Mol Sci. 2011. PMID: 21686180 Free PMC article. Review.
Testing the metal of ERCC2 in predicting the response to platinum-based therapy.
Turchi JJ, Woods DS, VanderVere-Carozza P. Turchi JJ, et al. Cancer Discov. 2014 Oct;4(10):1118-9. doi: 10.1158/2159-8290.CD-14-0893. Cancer Discov. 2014. PMID: 25274682 Free PMC article.
Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.
Earley JN, Turchi JJ. Earley JN, et al. Antioxid Redox Signal. 2011 Jun 15;14(12):2465-77. doi: 10.1089/ars.2010.3369. Epub 2011 Jan 23. Antioxid Redox Signal. 2011. PMID: 20812782 Free PMC article.
Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease.
Nagel ZD, Engelward BP, Brenner DJ, Begley TJ, Sobol RW, Bielas JH, Stambrook PJ, Wei Q, Hu JJ, Terry MB, Dilworth C, McAllister KA, Reinlib L, Worth L, Shaughnessy DT. Nagel ZD, et al. Mutat Res. 2017 Aug;800-802:14-28. doi: 10.1016/j.mrfmmm.2017.03.007. Epub 2017 Apr 6. Mutat Res. 2017. PMID: 28458064 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon